Slit valves hold 36.0% share, while colonoscopy accounts for 39.0% of procedure demand; U.S. market projected to expand at 7.3% CAGR through 2036
Rockville, Maryland — September 24, 2026 — Demand for single-use biopsy valves is projected to increase from USD 228 million in 2026 to USD 445 million by 2036, registering a 6.9% CAGR over the forecast period, according to Fact.MR research. Rising endoscopy procedure volumes and greater emphasis on infection prevention are encouraging healthcare facilities to adopt sterile, disposable accessories in place of reusable components.
Single-use biopsy valves are increasingly being incorporated into endoscopic procedures where reliable instrument access, sealing performance, and contamination control are essential. Their disposable design helps healthcare providers streamline accessory handling while reducing the need for cleaning, sterilization, and reprocessing between procedures.
Get detailed market forecasts, competitive benchmarking, and pricing trends:
Slit Valves Lead the Design Segment
Slit valves are expected to maintain their leading position within the design segment, accounting for 36.0% of the market in 2026. Their ability to provide dependable sealing during instrument exchange makes them suitable for procedures requiring repeated passage of biopsy forceps and other endoscopic instruments.
The demand for consistent sealing is particularly relevant in high-volume endoscopy environments. Manufacturers are therefore focusing on valve designs that support instrument compatibility while limiting fluid leakage and maintaining procedural efficiency.
As healthcare facilities continue to evaluate operating costs and infection-control requirements, single-use components can offer an alternative to reusable accessories that require post-procedure handling and sterilization.
Colonoscopy Represents the Largest Procedure Segment
Colonoscopy is projected to account for 39.0% of procedure demand in 2026, making it the largest procedure category for single-use biopsy valves.
Growing utilization of gastrointestinal diagnostic procedures is supporting demand for accessories that can be readily integrated into established endoscopy workflows. The expanding use of screening and diagnostic colonoscopy also creates opportunities for suppliers offering sterile products compatible with commonly used endoscopic platforms.
Hospitals remain the dominant end-user segment, representing 56.0% of the market in 2026. High procedure volumes and established infection-control protocols are contributing to continued adoption among hospital-based endoscopy departments.
United States Leads Country Growth
The United States is projected to record the highest CAGR of 7.3% through 2036 among the countries highlighted in the study. Expansion of gastrointestinal screening and continued adoption of sterile disposable accessories are supporting market growth.
The U.S. market is also benefiting from demand for efficient endoscopy workflows, with healthcare providers seeking accessories that can be deployed without the additional processing requirements associated with reusable components.
Germany is projected to expand at a 7.0% CAGR through 2036. Strong infection-control practices and investments in procedural efficiency are contributing to demand for single-use biopsy valves. The country’s established healthcare infrastructure also provides manufacturers with opportunities to expand their sterile endoscopy accessory portfolios.
In Japan, the market is expected to advance at a 6.8% CAGR during the same period. An aging population, increasing diagnostic procedure volumes, and the continued shift toward single-use healthcare products are supporting demand.
Together, these markets illustrate how infection prevention, procedure volumes, demographic trends, and healthcare workflow considerations are influencing the adoption of disposable endoscopy accessories.
Competitive Landscape
The competitive landscape includes established medical device and endoscopy companies such as Olympus, CONMED, US Endoscopy (STERIS), and Micro-Tech Endoscopy, alongside additional participants including Diversatek Healthcare.
Manufacturers are concentrating on several product-development priorities, including sealing performance, compatibility with endoscopic platforms, sterile packaging, and broader single-use product portfolios. Product differentiation is increasingly tied to how effectively biopsy valves support instrument exchange while maintaining procedural reliability.
As endoscopy volumes expand across hospitals and other healthcare settings, suppliers are expected to focus on products that can integrate into existing workflows without adding complexity to procedure preparation or post-procedure processing.
Unlock Actionable Insights from the Complete Report:
Market Outlook
The single-use biopsy valves market is positioned for continued expansion as healthcare providers place greater emphasis on infection prevention and efficient endoscopy operations. From USD 228 million in 2026, the market is forecast to reach USD 445 million by 2036, reflecting a 6.9% CAGR.
The United States, Germany, and Japan represent important growth markets, with projected CAGRs of 7.3%, 7.0%, and 6.8%, respectively. Meanwhile, slit valves, colonoscopy procedures, and hospitals remain significant market segments.
For deeper segment forecasts, country-level insights, competitive benchmarking, and pricing trends, explore the complete Fact.MR report on the Single-Use Biopsy Valves Market.
Explore More Related Studies Published by Fact.MR Research
Uveal Melanoma Treatment Market
About Fact.MR
Fact.MR is a global market research and consulting firm trusted by Fortune 500 companies and emerging businesses for market intelligence and strategic insights. With a presence across the U.S., UK, India, and Dubai, the company provides data-driven research and consulting solutions spanning more than 30 industries and 1,000 markets. Its research supports organizations in evaluating market opportunities, understanding competitive environments, and making informed business decisions.
Contact Us
11140 Rockville Pike, Suite 400
Rockville, MD 20852, United States
Tel: +1 (628) 251-1583
[email protected]
